東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Uremic toxins and organ failure

Saito, Hideyuki.

FindBook

Google Book

Amazon

博客來

Uremic toxins and organ failure

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Uremic toxins and organ failure/ edited by Hideyuki Saito, Takaaki Abe.
其他作者:	Saito, Hideyuki.
出版者:	Singapore :Springer Singapore : : 2020.,
面頁冊數:	viii, 180 p. :ill. (some col.), digital ;24 cm.
內容註:	1 Overview of Uremic Toxins -- 2 Review: Uremic toxins and gut microbiome -- 3 Gut microbiota and systemic uremic solute accumulation -- 4 Uremic toxin-related systemic disorders -- 5 Uremic Toxins and cardiovascular disease -- 6 Indoxyl sulfate and arteriosclerosis -- 7 Uremic Toxicity and Bone in CKD -- 8 D-serine as a novel uremic toxin -- 9 Uremic solutes and sarcopenia -- 10 Toxico-pathological role of hepatic sulfotransferase (SULT) 1A1 in acute kidney injuries -- 11 Accumulation of uremic toxins in systemic organs and the effect of AST-120.
Contained By:	Springer Nature eBook
標題:	Uremia. -
電子資源:	https://doi.org/10.1007/978-981-15-7793-2
ISBN:	9789811577932

Uremic toxins and organ failure
Uremic toxins and organ failure[electronic resource] /edited by Hideyuki Saito, Takaaki Abe. - Singapore :Springer Singapore :2020. - viii, 180 p. :ill. (some col.), digital ;24 cm.

1 Overview of Uremic Toxins -- 2 Review: Uremic toxins and gut microbiome -- 3 Gut microbiota and systemic uremic solute accumulation -- 4 Uremic toxin-related systemic disorders -- 5 Uremic Toxins and cardiovascular disease -- 6 Indoxyl sulfate and arteriosclerosis -- 7 Uremic Toxicity and Bone in CKD -- 8 D-serine as a novel uremic toxin -- 9 Uremic solutes and sarcopenia -- 10 Toxico-pathological role of hepatic sulfotransferase (SULT) 1A1 in acute kidney injuries -- 11 Accumulation of uremic toxins in systemic organs and the effect of AST-120.

This book describes the latest research on the gut-kidney axis of ureic solutes; the toxico-pathological mechanisms of uremic toxin-induced organ failure, including kidney and cardiovascular tissue; and the preventive therapeutic strategies for uremia and related organ failure associated with kidney injuries and diseases. Retained uremic toxins cause a variety of symptoms, such as hypertension, fatigue, renal anemia, osteoporosis and neurologic impairment, which are apparent in chronic kidney disease (CKD) patients. The human gastrointestinal tract contains trillions of microorganisms, referred to as gut microbiota, which support the host metabolism by producing nutrients, such as vitamins and short-chain fatty acids. However, they also produce various harmful uremic toxins that show renal and cardiovascular toxicity, and correlate with an increased mortality in CKD patients. The composition and balance of gut microbiota are associated with the accumulation of uremic toxins and the pathophysiology of CKD, and as such are being considered for a novel therapeutic strategy.

ISBN: 9789811577932

Standard No.: 10.1007/978-981-15-7793-2doiSubjects--Topical Terms:

2147219
Uremia.

LC Class. No.: RC915

Dewey Class. No.: 616.635

Uremic toxins and organ failure
LDR:02605nmm a2200325 a 4500 001 2256648
003 DE-He213
005 20201012134810.0
006 m d
007 cr nn 008maaau
008 220420s2020 si s 0 eng d
020 $a 9789811577932 $q (electronic bk.)
020 $a 9789811577925 $q (paper)
024 7 $a 10.1007/978-981-15-7793-2 $2 doi
035 $a 978-981-15-7793-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC915
072 7 $a MJR $2 bicssc
072 7 $a MED055000 $2 bisacsh
072 7 $a MJR $2 thema
082 0 4 $a 616.635 $2 23
090 $a RC915 $b .U75 2020
245 0 0 $a Uremic toxins and organ failure $h [electronic resource] / $c edited by Hideyuki Saito, Takaaki Abe.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2020.
300 $a viii, 180 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a 1 Overview of Uremic Toxins -- 2 Review: Uremic toxins and gut microbiome -- 3 Gut microbiota and systemic uremic solute accumulation -- 4 Uremic toxin-related systemic disorders -- 5 Uremic Toxins and cardiovascular disease -- 6 Indoxyl sulfate and arteriosclerosis -- 7 Uremic Toxicity and Bone in CKD -- 8 D-serine as a novel uremic toxin -- 9 Uremic solutes and sarcopenia -- 10 Toxico-pathological role of hepatic sulfotransferase (SULT) 1A1 in acute kidney injuries -- 11 Accumulation of uremic toxins in systemic organs and the effect of AST-120.
520 $a This book describes the latest research on the gut-kidney axis of ureic solutes; the toxico-pathological mechanisms of uremic toxin-induced organ failure, including kidney and cardiovascular tissue; and the preventive therapeutic strategies for uremia and related organ failure associated with kidney injuries and diseases. Retained uremic toxins cause a variety of symptoms, such as hypertension, fatigue, renal anemia, osteoporosis and neurologic impairment, which are apparent in chronic kidney disease (CKD) patients. The human gastrointestinal tract contains trillions of microorganisms, referred to as gut microbiota, which support the host metabolism by producing nutrients, such as vitamins and short-chain fatty acids. However, they also produce various harmful uremic toxins that show renal and cardiovascular toxicity, and correlate with an increased mortality in CKD patients. The composition and balance of gut microbiota are associated with the accumulation of uremic toxins and the pathophysiology of CKD, and as such are being considered for a novel therapeutic strategy.
650 0 $a Uremia. $3 2147219
650 0 $a Multiple organ failure. $3 1566205
650 1 4 $a Nephrology. $3 894870
650 2 4 $a Gastroenterology. $3 828956
650 2 4 $a Cardiology. $3 861477
700 1 $a Saito, Hideyuki. $3 3527149
700 1 $a Abe, Takaaki. $3 3527150
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-15-7793-2
950 $a Medicine (SpringerNature-11650)